Inhibition of NETosis by mitoTEMPO alleviates airway inflammation, NETs infiltration and production of NF-κB-dependent cytokines, but not type-I IFN, in the COPD mouse model. Here, NFKB1 is linked to chronic obstructive pulmonary disease.